The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis

被引:118
作者
Schmit, X. [1 ]
Vincent, J. L. [1 ]
机构
[1] Erasme Univ Hosp, Dept Intens Care Med, B-1070 Brussels, Belgium
关键词
D O I
10.1007/s15010-007-7077-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: C-reactive protein (CRP) may be a useful marker of sepsis but its use in the evaluation of response to therapy remains poorly defined. The aim of this study was to define the time course of CRP levels in septic patients according to their response to initial antimicrobial treatment, and to search for possible correlations between CRP levels and other clinical and biological variables. Patients and Methods: This prospective, observational, multicenter study included all critically ill patients with sepsis admitted to two medico-surgical departments of intensive care in Brussels, Belgium during a 5-month period. CRP levels and standard clinical and biological variables were measured daily from the day of sepsis diagnosis until death, transfer to the general floor, or the seventh day, whichever came first. Patients were divided into three groups according to their clinical course: group 1 - patients with a favorable response to initial antibiotic therapy; group 2 - patients who required a change in antibiotic therapy; group 3 patients who needed a procedure to control the infection. Results: CRP concentrations decreased more rapidly and to a greater degree in group I than in group 2 patients (p = 0.001). An increase in CRP of at least 2.2 mg/dl in the first 48 h was associated with ineffective initial antibiotic therapy with a sensitivity of 77% and a specificity of 67%. No correlation was found between CRP levels and other clinical and biological variables. Conclusion: Changes in CRP levels over the first 48 h of therapy can help to evaluate the response to initial antimicrobial therapy in septic patients.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 27 条
[1]   Inflammation and endothelial function - Direct vascular effects of human C-reactive protein on nitric oxide bioavailability [J].
Clapp, BR ;
Hirschfield, GM ;
Storry, C ;
Gallimore, JR ;
Stidwill, RP ;
Singer, M ;
Deanfield, JE ;
MacAllister, RJ ;
Pepys, MB ;
Vallance, P ;
Hingorani, AD .
CIRCULATION, 2005, 111 (12) :1530-1536
[2]   Diagnostic and prognostic value of procalcitonin in patients with septic shock [J].
Clec'h, C ;
Ferriere, F ;
Karoubi, P ;
Fosse, JP ;
Cupa, M ;
Hoang, P ;
Cohen, Y .
CRITICAL CARE MEDICINE, 2004, 32 (05) :1166-1169
[3]   C-reactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection [J].
Férard, G ;
Gaudias, J ;
Bourguignat, A ;
Ingenbleek, Y .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (12) :1334-1338
[4]   Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis [J].
Harbarth, S ;
Holeckova, K ;
Froidevaux, C ;
Pittet, D ;
Ricou, B ;
Grau, GE ;
Vadas, L ;
Pugin, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) :396-402
[5]   Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis [J].
Harbarth, S ;
Garbino, J ;
Pugin, J ;
Romand, JA ;
Lew, D ;
Pittet, D .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (07) :529-535
[6]   Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient [J].
Hogarth, MB ;
Gallimore, JR ;
Savage, P ;
Palmer, AJ ;
Starr, JM ;
Bulpitt, CJ ;
Pepys, MB .
AGE AND AGEING, 1997, 26 (02) :153-158
[7]   Clinical applications of C-reactive protein in pediatrics [J].
Jaye, DL ;
Waites, KB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (08) :735-747
[8]   2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference [J].
Levy, MM ;
Fink, MP ;
Marshall, JC ;
Abraham, E ;
Angus, D ;
Cook, D ;
Cohen, J ;
Opal, SM ;
Vincent, JL ;
Ramsay, G .
CRITICAL CARE MEDICINE, 2003, 31 (04) :1250-1256
[9]   C-reactive protein levels correlate with mortality and organ failure in critically ill patients [J].
Lobo, SMA ;
Lobo, FRM ;
Bota, DP ;
Lopes-Ferreira, F ;
Soliman, HM ;
Mélot, C ;
Vincent, JL .
CHEST, 2003, 123 (06) :2043-2049
[10]   Adequacy of early empiric antibiotic treatment and survival in severe sepsis: Experience from the MONARCS trial [J].
MacArthur, RD ;
Miller, M ;
Albertson, T ;
Panacek, E ;
Johnson, D ;
Teoh, L ;
Barchuk, W .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (02) :284-288